Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Billiouw, Jean-Marie" or (type any "bookEditor issueEditor" and editor="Billiouw, Jean-Ma...

Add to list
- Conference Paper
- C3
Fibromuscular dysplasia : results of a multicentre study in Flanders

Marie De Groote (UGent) , Dimitri Hemelsoet (UGent) , Patricia Van der Niepen, Bert Callewaert (UGent) , Frank Vermassen (UGent) , Jean-Marie Billiouw, An De Vriese, Jan Donck and Tine De Backer (UGent)

(2017) ACTA CARDIOLOGICA. 72(1). p.113-113
Add to list
Fibromuscular dysplasia : results of a multicentre study in Flanders

Marie De Groote (UGent) , Patricia Van der Niepen, Dimitri Hemelsoet (UGent) , Bert Callewaert (UGent) , Frank Vermassen (UGent) , Jean-Marie Billiouw, An De Vriese, Jan Donck and Tine De Backer (UGent)

(2017) VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 46(3). p.211-218
Add to list
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)

Gilbert Deray, Olivier Rouviere, Lorenzo Bacigalupo, Bart Maes, Thierry Hannedouche, François Vrtovsnik, Claire Rigothier, Jean-Marie Billiouw, Paolo Campioni, Joaquin Ferreiros, et al.

(2013) EUROPEAN RADIOLOGY. 23(5). p.1250-1259
Add to list
Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials

Christian L Tielemans, Jiri Vlasak, Dezider Kosa, Jean-Marie Billiouw, Gert A Verpooten, Ilona Mezei, Miroslav Ryba, Patrick Peeters (UGent) , Olivier Mat, Michel Y Jadoul, et al.

(2011) VACCINE. 29(6). p.1159-1166

Academic Bibliography

Fibromuscular dysplasia : results of a multicentre study in Flanders

Fibromuscular dysplasia : results of a multicentre study in Flanders

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)

Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials

Contents

Support

Contact